Injectable wireless nerve stimulator shows early preclinical feasibility

Researchers at NYU Abu Dhabi and Cleveland Clinic Abu Dhabi developed a miniature nerve stimulator designed for delivery through a standard needle rather than surgical implantation. The Science Advances study evaluated the technology in laboratory experiments and preclinical testing, including nerve activation in vivo. The supplied account does not specify the species, sample size, or quantitative performance endpoints.

The seed-sized device is positioned near a target nerve and delivers programmable electrical stimulation using power supplied wirelessly from outside the body, without batteries or connecting wires. Ultrasound and CT can be used to guide placement and check its position afterward. Researchers reported consistent performance under conditions intended to resemble real-world use and demonstrated nerve activation within a living organism, but the account provides no numerical results.

The technology could offer a less invasive approach to implanted neuromodulation. However, nerve activation is a feasibility finding, not evidence of clinical benefit for chronic pain or movement disorders. Human efficacy has not been established, and further safety and effectiveness research is needed. The supplied report is a university-sourced news account; claims of reduced procedural risks or faster recovery remain potential benefits rather than demonstrated outcomes.